Laurent Higueret
Directeur/Bestuurslid bij DNA Script SAS
Oorsprong van het eerstegraads netwerk van Laurent Higueret
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development.
75
| Subsidiary | Investment Managers | 75 |
DNA Script SAS
 DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France.
14
| Holding Company | Medical Specialties | 14 |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.
13
| Holding Company | Biotechnology | 13 |
TreeFrog Therapeutics SAS
 TreeFrog Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services TreeFrog Therapeutics SAS provides stem cell treatment services. It offers its expertise to patients of heart failure, diabetes, traumatic injury, skin burns, dermatitis, Huntington, and Parkinson disease. The company was founded by Maxime Feyeux, Kevin Alessandri, Jean-Luc Treillou, Erwan Bezard, Laurent Cognet, and Pierre Nassoy and is headquartered in Pessac, France.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Owkin France SASU
 Owkin France SASU Medical/Nursing ServicesHealth Services Owkin France SAS provides artificial intelligence for predictive medicine. The company was founded on September 7, 2016 and is headquartered in Paris, France.
3
| Subsidiary | Medical/Nursing Services | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Laurent Higueret via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Ecole Polytechnique | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| TXCELL | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
Bpifrance Participations SA /PRIVATE EQUITY/
 Bpifrance Participations SA /PRIVATE EQUITY/ Investment ManagersFinance Bpifrance Participations SA/ PRIVATE EQUITY/ (BPIfrance Participations PE) is the private equity division of Bpifrance Participations SA subsidiary of State-owned Caisse des Dépots & Consignations headquartered in France. Formerly known as Fonds Stratégique d'Investissement SA (Private Equity), the firm was established in 2008 by the Government of France in an aim to strengthen distressed companies of strategic importance for the French economy. Based in Paris, BPIfrance Participations specializes in fund of funds and direct investments in French intermediate-sized companies. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Analyst Private Equity Investor Private Equity Analyst Private Equity Analyst | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | |
| SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| ADVICENNE | Pharmaceuticals: Generic | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| SANOFI | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor | |
CDC Enterprises, Inc.
 CDC Enterprises, Inc. Electrical ProductsProducer Manufacturing CDC Enterprises, Inc. designs, manufactures, and distributes patented HDPE ductwork products. It offers airtight, mildew, corrosion resistant, and thermal constructed ductwork products. The firm specializes in electrical instrumentation, controls and systems integration, for public works, utilities, private industry, and government organizations. It provides a wide range of services including pump efficiency monitoring, system diagnostics and troubleshooting, GPS mapping, robotic controls, panel design, and fabrication. The company was founded by Jon W. Jungers in April 2001 and is headquartered in Ringwood, IL. | Electrical Products | Chief Investment Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
CDC Croissance SA
 CDC Croissance SA Investment ManagersFinance CDC Croissance SA is an asset management firm headquartered in Paris, France. It was founded in 2001 as CDC Entreprises Valeurs Moyennes SAS. The firm is a subsidiary of BPIFrance Investissement, which in turn is a subsidiary of government-owned Caisse d'Amortissement de la Dette Sociale. CDC Croissance manages assets of individual and institutional clients. | Investment Managers | Chief Investment Officer Corporate Officer/Principal Chief Executive Officer | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| POXEL | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| PIXIUM VISION | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
GamaMabs Pharma SA
 GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
ADEMTECH SA
 ADEMTECH SA Miscellaneous Commercial ServicesCommercial Services ADEMTECH SA specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications. The firm produces magnetic nanoparticles for concentration, separation, purification, microfluidic device integration and identification of molecules and specific cells. The company was founded in 2000 and is headquartered in Pessac, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer Director/Board Member Chairman | |
| MORGAN STANLEY | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Université Paris II Panthéon Assas | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| ORANGE | Wireless Telecommunications | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor General Counsel | |
| ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| EUTELSAT COMMUNICATIONS | Major Telecommunications | Director/Board Member Director/Board Member Director/Board Member | |
| Université Paris Dauphine-PSL | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| MERSEN | Electrical Products | Director/Board Member Director/Board Member Director/Board Member | |
| VERGNET S.A. | Electrical Products | Director/Board Member Director/Board Member Director/Board Member | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| INTEGRAGEN | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Tissium SA
 Tissium SA BiotechnologyHealth Technology Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Director/Board Member Chief Tech/Sci/R&D Officer | |
Orphalan SA
 Orphalan SA Pharmaceuticals: MajorHealth Technology GMP-Orphan SA engages in the research and development in biotechnology. It focuses on developing and designing drugs for life-threatening and rare diseases. The company was founded by Frederic Marin on July 18, 2011 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| THERADIAG | Medical Specialties | Director/Board Member Director of Finance/CFO | |
Amundi Private Equity Funds SA
 Amundi Private Equity Funds SA Investment ManagersFinance Amundi Private Equity Funds SA (Amundi PEF) is the private equity subsidiary of Amundi SA, itself a subsidiary of Crédit Agricole SA (XP: ACA) in France. Formerly known as CAAM-CI, founded in 1999 as CPR Private Equity, Amundi PEF was formed in 2009 by combining the Crédit Agricole and Société Générale asset management operations. The firm is headquartered in Paris and has additional offices in Bucharest, Cairo, Casablanca, Tunis and Warsaw. They invest in companies at all stages of development, providing institutional and individual investors with a wide spectrum of investment opportunities. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| University of Bath | College/University | Undergraduate Degree Undergraduate Degree | |
| ALBIOMA | Alternative Power Generation | Director/Board Member Director/Board Member | |
FT1CI
 FT1CI Other Metals/MineralsNon-Energy Minerals FT1CI provides services to nuclear power plants such as uranium mining and fuel production, maintenance and engineering services, recycling and processing of nuclear waste, and manufactures nuclear power generation, transmission and distribution equipment. It is headquartered in Paris, France. | Other Metals/Minerals | Chief Executive Officer Director/Board Member | |
Oddo BHF SCA (Broker)
 Oddo BHF SCA (Broker) Investment Banks/BrokersFinance Oddo BHF SCA (Broker) is the securities brokerage division of Oddo BHF SCA, a financial services company headquartered in Paris, France. The firm provides equity brokerage services to various investors. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Banque Publique d'Investissement
 Banque Publique d'Investissement Finance/Rental/LeasingFinance Banque Publique Dinvestissement (Bpifrance) is the French Government's public investment institution which was created in 2013 to 'serve the future' by providing financing solutions tailored to each stage of a company's life. Located in Maisons-Alfort, Bpifrance aims to invest EUR 12 billion in French companies by 2017. Their three main tasks are: to help overcome market failures that hamper the financing of enterprises, especially SMEs; to invest in the development of strategic sectors such as digital conversion, environmental and energy, and the social and solidarity economy; and to act as a lever to develop territories in connection with regions in France. Bpifrance includes OSEO, CDC Entreprises, FSI and FSI Regions. OSEO is a public institution whose mission is to support innovation and growth of SMEs. CDC Entreprises is a management company that invests directly or indirectly in SMEs and ETIs at all stages of their development. FSI is an investment fund established by the French government in 2008 to help French companies seeking stable investors to finance their development projects and FSI Régions is a management company which provides regional investment capital. In 2013, OSEO will become Bpifrance Financement and Bpifrance Investissement will regroup CDC Entreprises, FSI and FSI régions. CDC Entreprises, FSI and FSI Régions will merge to become Bpifrance Investment. | Finance/Rental/Leasing | Chief Executive Officer Corporate Officer/Principal | |
| Bpifrance Participations SA | Financial Conglomerates | Chief Executive Officer Chief Investment Officer | |
Bpifrance SA
 Bpifrance SA Finance/Rental/LeasingFinance Bpifrance SA provides aids and financial support to small and medium companies. Its solutions include loans, insurance, warranties, and equity investments. The creation of the BPI was formalized by Law no. 2012-1559 on 31 December 2012, amending Ordinance no. 2005-722 of June 29, 2005, relating to the creation of the public institution OSEO, which became EPIC BPI-Groupe then EPIC Bpifrance, and the public limited company OSEO (now Bpifrance). The company was founded in 1923 and headquartered in Maisons-Alfort, France. | Finance/Rental/Leasing | Chief Executive Officer Director/Board Member | |
Cornovum SASU
 Cornovum SASU Financial ConglomeratesFinance Cornovum SASU is an investment holding French company. The company is based in Paris, France. The company was founded in 2015. The CEO is Maïlys Ferrère. | Financial Conglomerates | Chief Executive Officer Chairman | |
PALUMED SA
 PALUMED SA Pharmaceuticals: MajorHealth Technology PALUMED SA develops and produces pharmaceutical products for the treatment of Alzheimer's disease. The firm specializes in the development and production of new antimalarial agents and antibacterial molecules. The company was founded on December 8, 2000 and is headquartered in Castanet-Tolosan, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VALNEVA | Biotechnology | Director/Board Member Director/Board Member | |
Novasep Holding SAS
 Novasep Holding SAS Chemicals: Major DiversifiedProcess Industries Novasep Holding SAS provides manufacturing solutions for the life science industries. Its products include agrochemicals fine chemicals and food ingredients. The company was founded by Roger-Marc Nicoud in 1995 and is headquartered in Lyon, France. | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
| École des Hautes Études Commerciales du Nord | College/University | Undergraduate Degree Graduate Degree | |
Groupe Limagrain Holding SA
 Groupe Limagrain Holding SA Agricultural Commodities/MillingProcess Industries Groupe Limagrain Holding SA engages in agricultural production. It offers wheat, corn, maize, sunflower, rapeseed, tomato, carrot, melon, cauliflower, and pepper, as well as flower seeds. The company was founded in 1965 and is headquartered in Saint-Beauzire, France. | Agricultural Commodities/Milling | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Frankrijk | 45 |
| Zwitserland | 4 |
| Verenigde Staten | 3 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 20 |
| Finance | 13 |
| Consumer Services | 7 |
| Producer Manufacturing | 4 |
| Commercial Services | 3 |
Operationeel
| Director/Board Member | 658 |
| Corporate Officer/Principal | 111 |
| Private Equity Investor | 85 |
| Independent Dir/Board Member | 67 |
| Chairman | 57 |
Sterkste connecties
| Insiders | |
|---|---|
| Anne-Sophie Herelle | 65 |
| Nicolas Dufourcq | 53 |
| Eli Casdin | 48 |
| Heiner Dreismann | 46 |
| Philippe Peltier | 45 |
| Vanessa Giraud | 41 |
| Nicholas Naclerio | 31 |
| Iain Dukes | 30 |
| Catherine Moukheibir | 29 |
| Chahra Khaoua Epouse Louafi | 26 |
| Maina Bhaman | 26 |
| Philippe Boucheron | 24 |
| Jean-Michel Petit | 24 |
| Jason Robert Dinges | 22 |
| Joachim Rothe | 22 |
- Beurs
- Insiders
- Laurent Higueret
- Bedrijfsconnecties
